Health

Tips on how to maintain a balanced lifestyle as a senior citizen

A BALANCED lifestyle refers to having a sense of control and well-being in all areas of life. According to an article published by Physio West, written by Bec Clare (2020), balanced living involves achieving optimal health in various aspects,...

A BALANCED lifestyle refers to having a sense of control and well-being in all areas of life. According to an article published by Physio West, written by Bec Clare (2020), balanced living involves achieving optimal health in various aspects,...

11 months 2 days ago

Health

Healthy eating made easy

ADOPTING A sustainable diet can offer numerous environmental, social, and health benefits. But when shifting to a sustainable way of eating, it is also important to plan ahead and choose foods that are both good for your body and the environment....

ADOPTING A sustainable diet can offer numerous environmental, social, and health benefits. But when shifting to a sustainable way of eating, it is also important to plan ahead and choose foods that are both good for your body and the environment....

11 months 2 days ago

Health – Dominican Today

Over 600 runners to compete in ninth edition of Bayahibe 10K

Bayahibe.- The ninth edition of the Bayahíbe race, set for September 22, will see at least 600 participants competing to support the Solca Foundation, which promotes social and educational projects for vulnerable youth.

Bayahibe.- The ninth edition of the Bayahíbe race, set for September 22, will see at least 600 participants competing to support the Solca Foundation, which promotes social and educational projects for vulnerable youth. The event is organized by the La Romana Bayahíbe Hotel Association (AHRB) and the La Romana Bayahibe Tourism Cluster (CTRB), with support from the Bayahíbe Municipal District.

The race will begin at 7:00 am from La Punta de Bayahíbe. Over 70 personnel from various security and emergency services, including the Tourist Police and the National Emergency System (911), will ensure runner safety. This year’s race, notable for its mixed asphalt and sand course, is described by Ana García-Sotoca of AHRB and CTRB as a milestone for integrating sports and offering a unique experience.

The event, supported by Santo Domingo Corre, expects 38% female participants, particularly between 30 and 50 years old. It is designed for runners aiming to complete the 10 kilometers in 40 to 55 minutes. Participants will receive medals, with prizes awarded to the top finishers in several categories. The event will also feature entertainment such as Zumba, a foam party, live DJs, and various raffles. Major sponsors include Mitur, Banreservas, and various local businesses and resorts.

11 months 3 days ago

Health, Local, Sports

STAT

STAT+: Pharmalittle: We’re reading about an Express Scripts lawsuit against FTC, AMR deaths, and more

Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus.

We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us. Our choice today is orange cream, for those tracking our habits. Meanwhile, here are a few items of interest. Hope you have a meaningful and productive day and, of course, do stay in touch. …

Express Scripts, which is one of the largest pharmacy benefit managers in the U.S., filed a lawsuit demanding that a recent Federal Trade Commission report accusing the industry middlemen of raising drug prices should be vacated, STAT tells us. In scathing language, the company argued the report was “seventy-four pages of unsupported innuendo leveled … under a false and defamatory headline.” The lawsuit also alleged the FTC “followed prejudice and politics, not evidence or sound economics, and wrongly concluded that PBMs inflate drug costs and harm independent pharmacies.” FTC Chair Lina Khan was also accused of “anti-PBM bias.”

Antimicrobial-resistant bacterial infections directly caused more than 1 million deaths worldwide annually from 1990 to 2021, and that number is projected to increase by almost 70% over the next 25 years, MedPage Today writes, citing an analysis in The Lancet. In 2021, 1.14 million deaths that were attributable to bacterial antimicrobial resistance occurred across the globe, slightly higher than the 1.06 million AMR-attributable deaths in 1990. Bacterial AMR was also associated with an estimated 4.71 million deaths in 2021, about the same as in 1990. By 2050, the researchers forecast that an estimated 1.91 million AMR-attributable deaths and 8.22 million AMR-associated deaths could occur every year worldwide. From 2025 to 2050, a cumulative 39.1 million deaths attributable to AMR could occur.

Continue to STAT+ to read the full story…

11 months 3 days ago

Pharma, Pharmalot, pharmalittle, STAT+

KFF Health News

Historic Numbers of Americans Live by Themselves as They Age

Gerri Norington, 78, never wanted to be on her own as she grew old.

But her first marriage ended in divorce, and her second husband died more than 30 years ago. When a five-year relationship came to a close in 2006, she found herself alone — a situation that has lasted since.

Gerri Norington, 78, never wanted to be on her own as she grew old.

But her first marriage ended in divorce, and her second husband died more than 30 years ago. When a five-year relationship came to a close in 2006, she found herself alone — a situation that has lasted since.

“I miss having a companion who I can talk to and ask ‘How was your day?’ or ‘What do you think of what’s going on in the world?’” said Norington, who lives in an apartment building for seniors on the South Side of Chicago. Although she has a loving daughter in the city, “I don’t want to be a burden to her,” she said.

Norington is part of a large but often overlooked group: the more than 16 million Americans living alone while growing old. Surprisingly little is known about their experiences.

This slice of the older population has significant health issues: Nearly 4 in 10 seniors living alone have vision or hearing loss, difficulty caring for themselves and living independently, problems with cognition, or other disabilities, according to a KFF analysis of 2022 census data.

If help at home isn’t available when needed — an altogether too common problem — being alone can magnify these difficulties and contribute to worsening health.

Studies find that seniors on their own are at higher risk of becoming isolated, depressed, and inactive, having accidents, and neglecting to care for themselves. As a result, they tend to be hospitalized more often and suffer earlier-than-expected deaths.

Getting medical services can be a problem, especially if older adults living alone reside in rural areas or don’t drive. Too often, experts observe, health care providers don’t ask about older adults’ living situations and are unaware of the challenges they face.

***

During the past six months, I’ve spoken to dozens of older adults who live alone either by choice or by circumstance — most commonly, a spouse’s death. Some have adult children or other close relatives who are involved in their lives; many don’t.

In lengthy conversations, these seniors expressed several common concerns: How did I end up alone at this time of life? Am I OK with that? Who can I call on for help? Who can make decisions on my behalf if I’m unable to? How long will I be able to take care of myself, and what will happen when I can’t?

This “gray revolution” in Americans’ living arrangements is fueled by longer life spans, rising rates of divorce and childlessness, smaller families, the geographic dispersion of family members, an emphasis on aging in place, and a preference for what Eric Klinenberg, a professor of sociology at New York University, calls “intimacy at a distance” — being close to family, but not too close.

The most reliable, up-to-date data about older adults who live alone comes from the U.S. Census Bureau. According to its 2023 Current Population Survey, about 28% of people 65 and older live by themselves, including slightly fewer than 6 million men and slightly more than 10 million women. (The figure doesn’t include seniors living in institutions, primarily assisted living and nursing homes.)

By contrast, 1 in 10 older Americans lived on their own in 1950.

This is, first and foremost, an older women’s issue, because women outlive men and because they’re less likely to remarry after being widowed or divorcing. Twenty-seven percent of women ages 65 to 74 live alone, compared with 21% of men. After age 75, an astonishing 43% of women live alone, compared with only 24% for men.

The majority — 80% — of people who live alone after age 65 are divorced or widowed, twice the rate of the general population, according to KFF’s analysis of 2022 census data. More than 20% have incomes below $13,590, the federal poverty line in 2022, while 27% make between that and $27,180, twice the poverty level.

***

Of course, their experiences vary considerably. How older adults living alone are faring depends on their financial status, their housing, their networks of friends and family members, and resources in the communities where they live.

Attitudes can make a difference. Many older adults relish being independent, while others feel abandoned. It’s common for loneliness to come and go, even among people who have caring friends and family members.

“I like being alone better than I like being in relationships,” said Janice Chavez of Denver, who said she’s in her 70s. “I don’t have to ask anybody for anything. If I want to sleep late, I sleep late. If I want to stay up and watch TV, I can. I do whatever I want to do. I love the independence and the freedom.”

Chavez is twice divorced and has been on her own since 1985. As a girl, she wanted to be married and have lots of kids, but “I picked jerks,” she said. She talks to her daughter, Tracy, every day, and is close to several neighbors. She lives in the home she grew up in, inherited from her mother in 1991. Her only sibling, a brother, died a dozen years ago.

In Chicago, Norington is wondering whether to stay in her senior building or move to the suburbs after her car was vandalized this year. “Since the pandemic, fear has almost paralyzed me from getting out as much as I would like,” she told me.

She’s a take-charge person who has been deeply involved in her community. In 2016, Norington started an organization for single Black seniors in Chicago that sponsored speed dating events and monthly socials for several years. She volunteered with a local medical center doing outreach to seniors and brought health and wellness classes to her building. She organized cruises for friends and acquaintances to the Caribbean and Hawaii in 2022 and 2023.

Now, every morning, Norington sends a spiritual text message to 40 people, who often respond with messages of their own. “It helps me to feel less alone, to feel a sense of inclusion,” she said.

In Maine, Ken Elliott, 77, a retired psychology professor, lives by himself in a house in Mount Vernon, a town of 1,700 people 20 miles northwest of the state capital. He never married and doesn’t have children. His only living relative is an 80-year-old brother in California.

For several years, Elliott has tried to raise the profile of solo agers among Maine policymakers and senior organizations. This began when Elliott started inquiring about resources available to older adults living by themselves, like him. How were they getting to doctor appointments? Who was helping when they came home from the hospital and needed assistance? What if they needed extra help in the home but couldn’t afford it?

To Elliott’s surprise, he found this group wasn’t on anyone’s radar, and he began advocating on solo agers’ behalf.

Now, Elliott is thinking about how to put together a team of people who can help him as he ages in place — and how to build a stronger sense of community. “Aging without a mythic family support system — which everyone assumes people have — is tough for everybody,” Elliott said.

In Manhattan, Lester Shane, 72, who never married or had children, lives by himself in an 11-by-14-foot studio apartment on the third floor of a building without an elevator. He didn’t make much money during a long career as an actor, a writer, and a theater director, and he’s not sure how he’ll make ends meet once he stops teaching at Pace University.

“There are days when I’m carrying my groceries up three flights of stairs when I think, ‘This is really hard,’” Shane told me. Although his health is pretty good, he knows that won’t last forever.

“I’m on all the lists for senior housing — all lottery situations. Most of the people I’ve talked to said you will probably die before your number comes up,” he said with mordant humor.

Then, Shane turned serious. “I’m old and getting older, and whatever problems I have now are only going to get worse,” he said. As is the case for many older adults who live alone, his friends are getting older and having difficulties of their own.

The prospect of having no one he knows well to turn to is alarming, Shane admitted: “Underneath that is fear.”

Kate Shulamit Fagan, 80, has lived on her own since 1979, after two divorces. “It was never my intention to live alone,” she told me in a lengthy phone conversation. “I expected that I would meet someone and start another relationship and somehow sail off into the rest of my life. It’s been exceedingly hard to give up that expectation.”

When I first spoke to Fagan, in mid-March, she was having difficulty in Philadelphia, where she’d moved two years earlier to be close to one of her sons. “I’ve been really lonely recently,” she told me, describing how difficult it was to adjust to a new life in a new place. Although her son was attentive, Fagan desperately missed the close circle of friends she’d left behind in St. Petersburg, Florida, where she’d lived and worked for 30 years.

Four and a half months later, when I called Fagan again, she’d returned to St. Petersburg and was renting a one-bedroom apartment in a senior building in the center of the city. She’d celebrated her birthday there with 10 close friends and was meeting people in her building. “I’m not completely settled, but I feel fabulous,” she told me.

What accounted for the change? “Here, I know if I want to go out or I need help, quite a few people would be there for me,” Fagan said. “The fear is gone.”

As I explore the lives of older adults living alone in the next several months, I’m eager to hear from people who are in this situation. If you’d like to share your stories, please send them to khn.navigatingaging@gmail.com.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

11 months 3 days ago

Aging, Navigating Aging, Public Health, Colorado, Illinois, Maine, New York, Pennsylvania

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Once-Weekly Insulin Efsitora Noninferior to Daily Basal Insulin in T2D, reveal QWINT Trials

Eli Lilly and Company today announced positive topline results from the QWINT-1 and QWINT-3 phase 3 clinical trials evaluating once weekly insulin efsitora alfa (efsitora) in adults with type 2 diabetes using basal insulin for the first time (insulin naïve) and in those who have switched from daily basal insulin injections, respectively.

In these long-term treat-to-target trials, efsitora showed non-inferior A1C reduction compared to the most frequently used daily basal insulins globally.

"Once weekly insulins, like efsitora, have the potential to transform diabetes care as we know it," said Jeff Emmick, M.D., Ph.D., senior vice president, product development, Lilly. "Many patients are reluctant to start insulin because of the burden it places on them. With a simple fixed-dose regimen, once-weekly efsitora could make it easier for people with diabetes to start and manage insulin therapy, while reducing the impact it has on their day-to-day lives."

QWINT-1 evaluated the efficacy and safety of once weekly efsitora compared to once daily insulin glargine for 52 weeks. The trial randomized adults with type 2 diabetes who are insulin naïve to receive either efsitora once weekly in a single-use autoinjector or insulin glargine once daily. Efsitora was titrated across four fixed doses at four-week intervals, as needed for blood glucose control. The study's goal was to provide data supporting real-life applications of fixed dose regimens, which have the potential to make it easier for people living with diabetes to start and manage insulin therapy.

The trial met its primary endpoint of non-inferior A1C reduction with efsitora compared to insulin glargine at week 52. For the efficacy estimand, efsitora reduced A1C by 1.31% compared to 1.27% for insulin glargine, resulting in an A1C of 6.92% and 6.96%, respectively4. For the treatment-regimen estimand, efsitora reduced A1C by 1.19% compared to 1.16% for insulin glargine, resulting in an A1C of 7.05% and 7.08%, respectively.

QWINT-3 evaluated the efficacy and safety of once weekly efsitora compared to once daily insulin degludec for 78 weeks in adults with type 2 diabetes currently treated with basal insulin. Participants were randomized 2:1 to receive either efsitora once weekly or insulin degludec once daily.

The QWINT-3 trial met its primary endpoint of non-inferior A1C reduction with efsitora compared to insulin degludec at week 26. For the efficacy estimand, efsitora reduced A1C by 0.86% compared to 0.75% for insulin degludec resulting in an A1C of 6.93% and 7.03%, respectively. For the treatment-regimen estimand, efsitora reduced A1C by 0.81% compared to 0.72% for insulin degludec resulting in an A1C of 6.99% and 7.08%, respectively.

Additionally, participants taking efsitora or insulin degludec spent approximately two hours more time in range (glucose 70-180 mg/dL) per day for weeks 22-26 compared to baseline. For the efficacy estimand, participants taking efsitora spent 62.8% of time in range compared to 61.3% for insulin degludec for weeks 22-26. For the treatment-regimen estimand, participants taking efsitora spent 61.4% of time in range compared to 61% for insulin degludec. Further, for the efficacy estimand, participants taking efsitora spent 38.3% of time in tight range (glucose 70-140 mg/dL) compared to 36.8% for insulin degludec for weeks 22-26.

In both QWINT-1 and QWINT-3, the overall safety and tolerability profile of efsitora was similar to that of daily basal insulin therapies for the treatment of type 2 diabetes. In QWINT-1, estimated combined rates of severe or clinically significant (blood glucose <54 mg/dL) hypoglycemic events per patient-year of exposure from weeks 0-52 were 0.50 with efsitora vs. 0.88 with insulin glargine – approximately 40% lower with efsitora than insulin glargine. In QWINT-3, estimated combined rates of severe or clinically significant (blood glucose <54 mg/dL) hypoglycemic events per patient-year of exposure from weeks 0-78 were 0.84 with efsitora vs. 0.74 with insulin degludec.

Detailed results for QWINT-1 and QWINT-3 will be shared at an upcoming congress and published in a peer-reviewed journal. Additionally, detailed results for QWINT-2 and QWINT-5 will be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024.

About the QWINT clinical trial program

The QWINT phase 3 global clinical development program for insulin efsitora alfa (efsitora) in diabetes began in 2022 and has enrolled more than 4,000 people living with type 1 or type 2 diabetes across five global registration studies.

QWINT-1 (NCT05662332) was a parallel-design, open-label, treat-to-target, randomized controlled clinical trial comparing the efficacy and safety of efsitora as a once weekly basal insulin using a fixed dose to insulin glargine for 52 weeks in insulin-naïve adults with type 2 diabetes. The trial randomized 796 participants across the U.S., Argentina, Mexico and Puerto Rico to receive efsitora once weekly or insulin glargine once daily administered subcutaneously. All participants treated with efsitora received a starting dose of 100 units followed by a fixed dose escalation to achieve a target fasting blood glucose of 80-130 mg/dL. Fasting blood glucose was measured every four weeks and participants escalated to fixed dosages of 150 units, 250 units and 400 units as appropriate. Participants with fasting blood glucose greater than 130 mg/dL on or after 16 weeks were transferred to flexible dosing. The primary objective of the trial was to demonstrate non-inferiority in reducing A1C at week 52 with efsitora compared to insulin glargine.

QWINT-3 (NCT05275400) was a multicenter, randomized, parallel-design, open-label trial comparing the efficacy and safety of efsitora as a once-weekly basal insulin to insulin degludec for 78 weeks after a three-week lead-in period, and followed by a five-week safety follow up period, in adults with type 2 diabetes who are currently treated with basal insulin. The trial randomized 986 participants across the U.S., Argentina, Hungary, Japan, Korea, Poland, Puerto Rico, Slovakia, Spain and Taiwan to receive efsitora once weekly or insulin degludec once daily administered subcutaneously. The primary objective of the study was to demonstrate non-inferiority in reducing A1C at week 26 with efsitora compared to insulin degludec.

About insulin efsitora alfa

Insulin efsitora alfa (efsitora) is a once-weekly basal insulin, a fusion protein that combines a novel single-chain variant of insulin with a human IgG2 Fc domain. It is specifically designed for once-weekly subcutaneous administration, and with its low peak-to-trough ratio, it has the potential to provide more stable glucose levels (less glucose variability) throughout the week. Efsitora is in phase 3 development for adults with type 1 and 2 diabetes.

11 months 3 days ago

Diabetes and Endocrinology,Medicine,Diabetes and Endocrinology News,Medicine News,Top Medical News,Latest Medical News

Health News Today on Fox News

'Vaccine fatigue' blamed as roughly half of people in US will skip COVID and flu shots this year

A growing number of U.S. adults are hesitant to get recommended vaccines this fall, a new survey found.

The poll, which included 1,006 people, found that only 43% of respondents have gotten or plan to get the COVID vaccine.

A growing number of U.S. adults are hesitant to get recommended vaccines this fall, a new survey found.

The poll, which included 1,006 people, found that only 43% of respondents have gotten or plan to get the COVID vaccine.

Only a slight majority (56%) of adults said they have gotten or plan to get the flu shot this fall.

COVID VACCINE DISTRUST GROWING AMONG AMERICANS, SURVEY FINDS: ‘SHOULD BE A PERSONAL CHOICE’

The poll also found that 37% of those who have gotten vaccines in past years plan to skip the shots this season. 

Around one-third of respondents also said they don’t believe they need the vaccines mentioned in the survey — flu, COVID, RSV or pneumococcal pneumonia.

Vaccine hesitancy tends to skew younger, as adults aged 65 and older are the most likely to get the recommended immunizations.

The nationwide survey was conducted by The Ohio State University Wexner Medical Center in mid-August 2024.

NEW COVID VACCINES GET FDA APPROVAL FOR 2024-2025 SEASON

These findings come just weeks after the U.S. Food and Drug Administration (FDA) approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season.

"We’re at the start of respiratory virus season, when you have the triple threat of flu, COVID-19 and RSV," said Nora Colburn, MD, medical director of clinical epidemiology at Ohio State’s Richard M. Ross Heart Hospital, in a press release.

"Unfortunately, there is a lot of misinformation about vaccinations, but the reality is that they are safe and highly effective in preventing serious illness and death," she went on.

"Older adults, people with certain chronic medical conditions, and those who are pregnant are especially at risk during respiratory virus season."

Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, reacted to the poll’s findings.

"It’s obviously not surprising that 37% of people said they had been vaccinated in the past but weren’t planning to this year," he told Fox News Digital. 

RISKS ASSOCIATED WITH THE COVID VACCINE IDENTIFIED IN STUDY

"We just had a vaccine mandate a couple of years ago, and furthermore, childhood vaccines are very broadly administered, so those 37% are people who wouldn’t be getting a vaccine normally anyway."

The reported rate of 56% for the flu shot is a little above average, Glanville said, as it tends to hover at around 50%.

"Coronavirus vaccination rates are a little lower than for the flu," he noted. 

This could be due to lack of clarity with the public over how COVID should be treated post-pandemic, according to Glanville.

"It’s also fatigue due to the COVID vaccines not being particularly effective at preventing symptoms, which causes people to believe that they are not effective (although they do protect against severe illness)," he added.

Dr. Marc Siegel, senior medical analyst for Fox News and clinical professor of medicine at NYU Langone Medical Center, said he finds the poll’s findings concerning.

"Both vaccines wane over six months, so a yearly booster makes sense for high-risk groups," he told Fox News Digital.

Siegel estimates that this year’s flu season will be similar to last year’s, which was "moderate," with 25,000 deaths and 400,000 hospitalizations. 

"The flu shot decreases severity and number of hospitalizations by about a quarter, and helps to provide community immunity," he added.

FIRST CASE OF HUMAN BIRD FLU DIAGNOSED WITHOUT EXPOSURE TO INFECTED ANIMALS, CDC SAYS

For COVID, Siegel warned that the virus’ activity is still fairly high — "especially in the western U.S."

The doctor also warned of a new variant circulating in Europe, which he expects will soon be in the U.S., known as the XEC subvariant.

"It seems to be more contagious — it causes congestion, cough, loss of smell and appetite, sore throat and body aches," he told Fox News Digital.

"The new vaccine should provide at least some coverage."

Dr. Paul Offit, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, told Siegel that very young children are being hospitalized at a greater rate — "likely because they haven't been vaccinated with the primary series."

"I recommend a yearly booster for the elderly, immunocompromised and those with chronic illness, along with anyone who is at risk for long COVID or has had it previously," Siegel said.

The U.S. Centers for Disease Control and Prevention (CDC) has issued the following vaccine recommendations.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Flu: Everyone 6 months and older is advised to get vaccinated against influenza.

COVID-19: The latest version of the COVID vaccine is recommended for everyone 6 months and older.

RSV: The respiratory syncytial virus (RSV) vaccine is recommended for everyone aged 75 and older, as well as those aged 60 to 74 who have certain chronic medical conditions, such as lung or heart disease, or who live in nursing homes, as they are at a higher risk of severe disease. Pregnant women are also advised to get the vaccine during weeks 32 through 36 of pregnancy.

Pneumococcal: Everyone younger than 5 years and age 65 and older is advised to get the pneumococcal vaccine, along with those who are at increased risk of severe disease.

For more Health articles, visit www.foxnews.com/health

Fox News Digital reached out to the OSU research team for comment.

11 months 3 days ago

Health, vaccines, infectious-disease, coronavirus, cold-and-flu, healthy-living, lifestyle

Health | NOW Grenada

Delma Thomas appointed to serve as minister for 2 ministries

Delma Thomas has been appointed to serve as the Minister for Youth and Sports and as Minister for Mental Health, two separate ministerial portfolios with the same Permanent Secretary

11 months 4 days ago

Health, Politics, Sports, Youth, cecile la grenade, david andrew, delma thomas, government gazette, kim frederick, linda straker, public seal, seville francis, tillman thomas

Healio News

Switching to upadacitinib superior to cycling TNF inhibitors in rheumatoid arthritis

Switching from a TNF inhibitor to upadacitinib leads to significantly better outcomes in rheumatoid arthritis vs.

cycling TNF inhibitors or switching to another mechanism of action, according to data published in Advances in Therapy.Specifically, patients who switched to upadacitinib (Rinvoq, Abbvie) demonstrated superior chances of remission, no pain and complete adherence to therapy, compared with those who cycled or moved on to another mechanism.“Tumor necrosis factor inhibitors (TNFis) are often the first choice of targeted therapy for RA; however, many patients do not achieve

11 months 4 days ago

Health Archives - Barbados Today

Fogging in St Michael and St Joseph this week

The Vector Control Unit will visit communities in St Michael and St Joseph when it conducts its fogging exercise this week.

The team will focus on mosquito breeding sites in St Michael, from Monday to Wednesday, before moving on to St Joseph on Thursday and Friday.

The Vector Control Unit will visit communities in St Michael and St Joseph when it conducts its fogging exercise this week.

The team will focus on mosquito breeding sites in St Michael, from Monday to Wednesday, before moving on to St Joseph on Thursday and Friday.

On Monday, the Unit will fog Hindsbury Road, Tudor Road, Dr Kerr Land, Mottley Land, Prescod Bottom, Brathwaite Road, Progressive Road, Field Gap, Country Road, Laundry Road and environs.

The Unit will concentrate its efforts on Station Hill, Goodings Road with avenues, Bellevue Gap, and Deane’s Village on Tuesday.

The following districts will be sprayed on Wednesday: Mansion Road, Lower Bank Hall Cross Road, Prince of Wales, Queen Mary Road, King George Road, King Edward Road, Queen Victoria Road, Buckingham Road, 2nd Avenue Sealy Land, Gilkes Road, Powder Road, and Happy Cot.

On Thursday, several areas in St Joseph will be targeted for fogging. These include Blackmans Tenantry, Horse Hill, Blackman Development, Tourville, Bonwell Road, Surinam Road, Vaughn Road Nos. 1, 2 and 3, and Quarry Road.

The fogging exercise for the week will conclude on Friday, in the following St Joseph communities: Gaggs Hill, Hillswick Road, Phillips Road, Cleavers Hill, Bathsheba, Elizabeth Village, St Elizabeth New Road, and Foster Hall.

Fogging takes place from 4:30 to 8:30 p.m. daily. Householders are reminded to open their windows and doors to allow the spray to enter. Children should not be allowed to play in the spray.

Members of the public are advised that the completion of scheduled fogging activities may be affected by events beyond the Unit’s control. In such circumstances, the Unit will return to communities affected in the soonest possible time.

The post Fogging in St Michael and St Joseph this week appeared first on Barbados Today.

11 months 5 days ago

Health, Local News

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

US FDA nod to Eli Lilly's Eczema drug Ebglyss

Bengaluru: Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old.

The drug, which is an injectable medicine and branded Ebglyss, will be available in the next few weeks, the company said.Read Also: Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countriesEczema, also known as atopic dermatitis, is an inflammatory skin condition that can cause itching, rashes and dry patches.The FDA's approval was based on three studies involving over 1,000 patients with moderate-to-severe eczema who were unable to control their symptoms with topical medicines or other systemic treatments, Eli Lilly said.Last year, the regulator had declined to approve the drug due to certain findings during an inspection of a contract manufacturer.Nearly 16.5 million adults in the U.S. have eczema, according to the National Eczema Association.Eczema has multiple treatments available, including AbbVie's Rinvoq, Pfizer's Cibinqo, Sanofi and Regeneron's Dupixent as well as some generic drugs such as cetirizine.Unlike Dupixent, which has to be dosed twice a month for adults, Ebglyss can be dosed once-monthly, which is "viewed as attractive by experts and likely also patients," Jefferies analyst Lucy Codrington wrote in a note last year.The drug is already approved for use in Europe and Japan, with additional markets expected later this year, the company said.Ebglyss is a monoclonal antibody that selectively targets and neutralizes the IL-13 protein that causes progression of eczema.Read Also: Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease

11 months 5 days ago

News,Medicine,Medicine News,Industry,Pharma News,Latest Industry News

Health Archives - Barbados Today

Promising improvement in vaccination rates, Health Ministry says

Vaccine coverage among primary school aged children remains high, but still not at optimum levels, the Ministry of Health says.

The ministry says the last statistics recorded at the end of 2023, show that there has been a promising improvement in vaccination rates over the years, but the 95 per cent coverage point has still not been achieved.

Vaccine coverage among primary school aged children remains high, but still not at optimum levels, the Ministry of Health says.

The ministry says the last statistics recorded at the end of 2023, show that there has been a promising improvement in vaccination rates over the years, but the 95 per cent coverage point has still not been achieved.

The statement said, “Barbados in 2023, coverage of primary vaccines was 85 per cent for Diphtheria tetanus toxoid and pertussis [DTP3] and Polio and MMR1 and 2 was 90 per cent and 76 per cent respectively. This was an improvement from the coverage achieved in 2021 and 2022 for MMR, however, the DTP3 and Polio3 coverage was similar to that seen in 2020 and slightly less than that for 2022. Overall, the coverage of primary vaccines is still below the targeted 95 percent coverage.”

Meanwhile, Veronica Kirton, acting senior health sister at the Edgar Cochrane Polyclinic, told Barbados TODAY on Saturday during a visit to the facility, that there has been a steady flow of parents bringing their children in for their shots.

“Right now we are seeing a steady flow of persons coming in for the vaccines, we’ve not really had any vaccine hesitancy per say. We’ve had some children who would have defaulted, and because we are open today, Saturday, which we normally wouldn’t do, we’ve had a few parents coming in bringing their children for the vaccines,” she said.  

Kirton pointed out that Mondays are typically designated as childhood days at the polyclinic, which typically covered vaccination appointments. She added that there has been a consistent flow of children, aged two months to five years, as well as those seeking to update their vaccinations after sitting the Common Entrance Examinations.

“What we do is that we organise a programme where we do a particular school on a set day and then after that, we have a day where persons who probably would have missed the vaccines would come on that day to get the vaccines.

“[On average] we tend to get probably 20 children per week at this location, coming in.” (SB)

The post Promising improvement in vaccination rates, Health Ministry says appeared first on Barbados Today.

11 months 5 days ago

Health, Local News

News Archives - Healthy Caribbean Coalition

Caribbean Wellness Day – Messages from Across the Region

Caribbean Wellness Day (CWD) is one of the regional responses geared towards increasing awareness and promoting measures among CARICOM Member States and their populations, to address the epidemic of non-communicable diseases (NCDs), which continue to severely impact the health, economy and developm

Caribbean Wellness Day (CWD) is one of the regional responses geared towards increasing awareness and promoting measures among CARICOM Member States and their populations, to address the epidemic of non-communicable diseases (NCDs), which continue to severely impact the health, economy and development of the Caribbean region.

The theme is – Power Through Collective Action: Good Health is Our Right.

A Message from the President of the HCC

A Message from Dr Kenneth Connell – President, Healthy Caribbean Coalition on this the occasion of Caribbean Wellness Day 2024

A Statement from the Healthy Caribbean Coalition on Caribbean Wellness Day 2024

The HCC – an alliance of over 85 civil Society organisations across the Caribbean – is proud join with partners the Caribbean Public Health Agency (CARPHA), The Pan American Health Organization (PAHO), CARICOM and Ministries of Health to celebrate Caribbean Wellness Day 2024 under the theme Power Through Collective Action: Good Health is Our Right.

As we look towards the 4th United Nations High Level Meeting on NCDs (HLM4) one year away in September 2025, and beyond to the 2030 Sustainable Development Goals (SDGs), the HCC recalls the vision and leadership of CARICOM Heads of Government seventeen years ago when they endorsed the Port of Spain Declaration on NCDs (POSD). This seminal document embodied the theme of Collective Action – recognising the need for a whole of society and whole of government response to NCDs and catalysing the global community around NCDs triggering the first UNHLM on NCDs in 2011. Although there has been some progress on the goals of the POSD, much remains to be done as evidenced by the 2022 WHO NCD Progress Monitor and the 2024 POS Tracking Grid (prepared by the Sir George Alleyne Chronic Disease Research Centre, UWI); and most concerning, by the continued unacceptably high burden of obesity and NCDs leading to preventable suffering and death of Caribbean citizens across our region.

This year’s CWD theme reminds us that Good Health is Our Right and we must continue to hold our leaders accountable to their commitments and play our respective roles in creating health-supporting environments. Over the next 12 months in lead up to the HLM4, HCC and our Caribbean CSO membership will join the global civil society community – under the banner TIME TO LEAD – calling on our political leaders to demonstrate fearless leadership in accelerating action on NCDs. As we did in 2018, HCC will unite with regional partners to agree on NCD advocacy priorities which will move us closer to achieving meaningful reductions in obesity and NCDs as we work towards achieving the SDGs.

On behalf of the Founding President and the Board of Directors of the HCC, we wish all Caribbean people a Happy Caribbean Wellness Day and look forward to leveraging the power of collective action to ensure every citizen’s right to good health as we work towards the prevention and control of NCDs in the Caribbean.

‘My Health My Right’ a Message from Members of the Healthy Caribbean Youth

Message from Dr Carla Barnett, CARICOM Secretary-General on Caribbean Wellness Day 2024

Caribbean Wellness Day 2024 is being observed on Saturday, 14 September, under the 2020-2024 theme, ‘Power through Collective Action’, and the 2024 sub-theme ‘Good Health is our Right!

The observation of this day has its roots in the Port of Spain Declaration on Non-Communicable Diseases (NCDs) of 2007, which expressed the commitment of CARICOM Member States to ensure the good health and well-being of the people of the Caribbean Community (CARICOM).  It promotes awareness of the impact of NCDs on the people of the Caribbean, along with measures to reduce the incidence of NCDs.

Influencing and empowering individuals to make healthier choices requires collective action and a multisectoral approach. National policies to support education on healthy food options, physical activity, and access to quality health services throughout the life course remain cornerstones to effectively address these diseases.

The Caribbean Community has been working to address NCDs, a leading cause of death in the Region, along with agencies such as the Caribbean Public Health Agency (CARPHA) and the Healthy Caribbean Coalition (HCC), an alliance of civil society to combat NCDs.  The Community’s initiatives to actively support the rights of citizens to good health include the ‘Tobacco-Free Caribbean’ and ‘Caribbean Moves’ initiatives.

CARICOM Heads of Government have prioritised addressing crime and violence as a public health issue. Dr the Honourable Keith Rowley, Prime Minister of Trinidad and Tobago, who leads on Energy and Security (Drugs and Illicit Arms) in the CARICOM Quasi-Cabinet, hosted a regional symposium in April 2023. A follow-up forum is to be hosted by the Honourable Mia Amor Mottley, Prime Minister of Barbados, in November this year, as the Community continues to focus on this scourge of violence, which impacts our right to health and safety.

The Community’s efforts to increase agricultural production is intended to support good health by making more fresh food available and affordable, thereby reducing the demand for imported foods which are preserved and contain unhealthy levels of salt and fats.

As we mark Caribbean Wellness Day, I urge all Member States to continue their efforts to address the Region’s health challenges through a whole-of-government and whole-of-society approach. I also encourage everyone to make those changes, such as consuming more fresh food and increasing activity levels, that will help to improve your health.

A healthy and happy Caribbean Wellness Day 2024 to all!

Caribbean Wellness Day 2024 | Official Statement by Dr. Lisa Indar Interim Executive Director, CARPHA

Regional Messages on Caribbean Wellness Day

The post Caribbean Wellness Day – Messages from Across the Region appeared first on Healthy Caribbean Coalition.

11 months 6 days ago

Latest, News, Slider

Health Archives - Barbados Today

Most hoteliers blanking tourism fund – BHTA

The Barbados Hotel and Tourism Association (BHTA) says the majority of hotels are not contributing to a crucial tourism fund, despite it being a requirement of membership.

Speaking at the association’s third quarterly general meeting at Stade’s Rum Visitors Centre in Brighton on Friday, BHTA Chairman Javon Griffith revealed that participation in the fund, established in 2003 to bolster tourism-related initiatives, has plummeted to a mere 26 per cent of hotel members.

“This is despite participation in the fund being a requirement of hotel membership via our articles of association. I cannot stress enough that this fund benefits the entire membership, but it’s being supported by a minority of hotel members,” Griffith said. “This situation is fundamentally wrong, and something which we will address over the coming weeks.”

The fund has historically financed various projects, including the restoration of the Holetown bridge, improvements to the Garrison Historic Area, and support for COVID-19 facilities. Contributions are primarily collected through a voluntary charge on hotel guests’ bills at checkout.

Griffith illustrated the potential impact of wider participation, stating that a 75-room hotel with typical seasonal occupancy could generate $59 000 annually for the fund, based on a US$2 ($4) per night contribution.

“I wish to see this fund grow to a level where the BHTA can make an even more significant contribution towards the tourism industry in collaboration with our partners at the BTMI,” he said, urging non-contributing members to contact the secretariat for information. (SB)

The post Most hoteliers blanking tourism fund – BHTA appeared first on Barbados Today.

11 months 6 days ago

Health, Local News

Pages